Trials / Completed
CompletedNCT00447967
Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients
A Randomized Phase II Study of Irinotecan and Oxaliplatin Versus the Combination of 5-FU/LV and Oxaliplatin, as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- Hellenic Oncology Research Group · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This phase II trial will compare the efficacy and toxicity of the combination of Irinotecan and Oxaliplatin versus 5-FU/LV and Oxaliplatin as first line treatment in patients with locally advanced or metastatic gastric cancer
Detailed description
There is no regimen considered standard in advanced gastric cancer. The reported response rates of 5-FU-based combination chemotherapy are higher than single agents (10-50%) but more toxic. The combination of 5-FU/LV and LOHP has demonstrated an ORR of 43%, median TTP of approximately 6,5 months and OS of 8,6 months in phase II trials, with an acceptable toxicity. Irinotecan (CPT-11) is effective as salvage treatment in metastatic gastric cancer and has a synergistic activity with LOHP in preclinical trials
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Irinotecan | Irinotecan 200 mg/m2 IV on Day 1 every 3 weeks for 6 cycles |
| DRUG | Oxaliplatin | Oxaliplatin 80 mg/m2 IV on Day 2 every 3 weeks for 6 cycles |
| DRUG | Fluorouracil | Fluorouracil 400 mg/m2 infused over 10 min IV and Fluorouracil600 mg/m2 infused over 22 hours IV, Day 1 and 2 (De Grammont regimen)every 2 weeks for 12 cycles |
| DRUG | Leucovorin | Leucovorin 200 mg/m2 infused over 1 hour IV on day 1 and day 2 (De Grammont regimen) every 2 weeks for 12 cycles |
| DRUG | Oxaliplatin | Oxaliplatin 85 mg/m2 as a 4 hour IV infusion, Day 1 every 4 weeks for 6 cycles |
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2007-03-15
- Last updated
- 2009-09-28
Locations
8 sites across 1 country: Greece
Source: ClinicalTrials.gov record NCT00447967. Inclusion in this directory is not an endorsement.